MiLaboratories

About:

MiLaboratories is a biotech company developing leading software platform for immune repertoire profiling

Website: https://milaboratories.com/

Top Investors: Speedinvest, K Fund, Courtyard Ventures, EGB Capital, Acrobator Ventures | Acrobator.vc

Description:

MiXCR is an ultimate software platform for analysis of Next-Generation Sequencing (NGS) data for immune profiling. It’s widely used to empower R&D in vaccine development, CAR-T therapies, antibody discovery and other areas. 8 out of 10 Big Pharma companies choose MiXCR for studying immune system. Aiming to support non-profit research, we provide MiXCR for free for academic and non-commercial use. For years, MiXCR is being the number one solution for immune system studies in academia and industry.

Total Funding Amount:

$12.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Sunnyvale, California, United States

Founded Date:

2021-01-01

Contact Email:

licensing(AT)milaboratories.com

Founders:

Alexey Nechaev, Dmitriy Bolotin, Dmitriy Chudakov, Stanislav Poslavsky

Number of Employees:

11-50

Last Funding Date:

2024-10-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai